文献速递淋巴瘤白血病

Should all patients with Hodgkin lymphoma who relapse after autologous SCT be considered for allogeneic SCT?

PubMed 文献 · Blood Adv · 2018-01-01

This article has a companion Counterpoint by Moskowitz.

原文

This article has a companion Counterpoint by Moskowitz.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Peggs KS. Should all patients with Hodgkin lymphoma who relapse after autologous SCT be considered for allogeneic SCT? Blood Adv. 2018. PMID: 29636327. doi:10.1182/bloodadvances.2017011122

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。